Created and led the GW Pharma International Medical organisation in preparation for the launch of Epidiolex®

Medical lead for the commercialisation of Sativex®

Member of the GW Pharma Clinical Development Committee and Corporate Drug Safety team

Led the GW global investigator initiated clinical studies program